Gary Johnson & Sam Johnson

• Gary is the Founder & Chairman of Inpharmation, Europe’s most respected pharma forecasting & pricing specialist consultancy, and the author of "Value Pricing for Market Access: Evidence-Based Pricing for Pharmaceuticals" and "Sales Forecasting for Pharmaceuticals: An Evidence Based Approach".

• As Board Director and Head of Research and Development, Sam leads the development of forecasting and pricing technologies at Inpharmation.

• Gary and Sam have been involved in the pricing and/or forecasting of around half of the new molecular entity launches over the past 5 years.

• Gary has been on CELforPharma faculty since 2007 and Sam joined our faculty in 2021. Their course content has evolved over the years, ensuring it remains up to date with new pharma market and technology developments. 

Learn from from Gary Johnson &Sam Johnson at the below courses: